Interestana
Home/News/Iran Faces Growing Medicine Shortages Amid Tightened US Sanctions
Al Jazeera3 min read

By Interestana AI Editorial — AI-drafted, human-overseen. How we report

Iran Faces Growing Medicine Shortages Amid Tightened US Sanctions

Iran is experiencing a significant and worsening shortage of essential medicines, with many citizens unable to access or afford life-saving drugs. This critical situation is directly linked to the tightening of United States sanctions, which Iranian officials and healthcare professionals describe as a de facto blockade on medical supplies. The sanctions, originally imposed to curb Iran's nuclear program, have increasingly impacted the nation's ability to import pharmaceuticals and medical equipment, despite stated US exemptions for humanitarian goods. The Iranian government has acknowledged the shortages but maintains that the domestic pharmaceutical sector will not collapse, emphasizing efforts to increase local production. However, reports from within the country indicate that the impact is already severe, with patients facing dire consequences. The scarcity affects a wide range of medications, including those for chronic diseases like cancer, diabetes, and heart conditions, as well as treatments for infectious diseases and specialized pediatric care. The cost of available medicines has also surged, placing them out of reach for a substantial portion of the population, particularly those with lower incomes. This economic strain exacerbates the health crisis, forcing difficult choices between essential medication and other basic necessities. The situation is further complicated by the complex and often opaque nature of international financial transactions, which are heavily scrutinized under the sanctions regime, making it difficult for Iranian entities to conduct legitimate trade even for exempted goods. The United Nations and various international humanitarian organizations have repeatedly called for the easing of sanctions, citing their detrimental impact on civilian populations, particularly in the healthcare sector. However, the US has largely maintained its stance, arguing that Iran's own policies and mismanagement contribute to the domestic challenges. The ongoing scarcity raises serious concerns about public health outcomes in Iran, potentially leading to increased morbidity and mortality rates if the situation is not addressed. The long-term implications for Iran's healthcare infrastructure and the well-being of its citizens are substantial, as the country grapples with both external economic pressures and internal challenges in ensuring access to fundamental medical care. The continued pressure from sanctions creates a complex humanitarian challenge that international bodies are closely monitoring.

Original source — read the full reporting at the publisher:

Read on Al Jazeera

Get the weekly AI digest

AI news + new model releases, weekly. Drafted by our agents, reviewed by humans.

Read next